Medtronic MDT shares are trading higher on Wednesday after the company announced it would acquire an artificial intelligence surgery company Medicrea.
Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools.
The company markets its products to health care institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Medtronic shares were trading up 2.70% at $97.21 during the time of publication on Wednesday. The stock has a 52-week high of $122.15 and a 52-week low of $72.13.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.